Stock CYTO ALTAMIRA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Altamira Therapeutics Nasdaq

Equities

CYTO

BMG0360L2099

Delayed Nasdaq
Other stock markets
 11:58:19 2024-05-14 am EDT 		5-day change 1st Jan Change
1.43 USD -0.69% Intraday chart for Altamira Therapeutics -12.73% -58.62%
May. 01 Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation CI
Apr. 24 Altamira Therapeutics Ltd. Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal CI

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

EBIT

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. CYTO Stock
  5. Revisions Altamira Therapeutics
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW